Insider trading

Period: 12 months Stock: CTNM + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

26 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

26 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

26 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

26 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
26 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
26 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

26 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
8 Sep 2026
Stengone Carmine N. CEO and President
Sold on a plan
$41.14K 2,500 at 16.46
12.7%
Planned (10b5-1)
3 Aug 2026
Stengone Carmine N. CEO and President
Sold on a plan
$40.03K 2,500 at 16.01
12.7%
Planned (10b5-1)
9 Jul 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan
$400.00 25 at 16.00
0.0%
Planned (10b5-1)
8 Jul 2026
Stengone Carmine N. CEO and President
Sold on a plan
$40.00K 2,500 at 16.00
12.7%
Planned (10b5-1)
8 Jul 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan
$16.24K 1,015 at 16.00
0.7%
Planned (10b5-1)
1 Jul 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan 2×
$132.29K 8,353 at 15.84
5.8%
Planned (10b5-1)
30 Jun 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan
$462.29K 28,826 at 16.04
17.1%
Planned (10b5-1)
30 Jun 2026
Watkins Tim CMO & Head of Development
Sold on a plan
$173.59K 10,833 at 16.02
54.7%
Sold half or more
30 Jun 2026
Stengone Carmine N. CEO and President
Sold on a plan
$160.08K 10,000 at 16.01
36.7%
Planned (10b5-1)
1 Jun 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan
$54.86K 4,170 at 13.16
2.9%
Planned (10b5-1)
1 May 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan 2×
$54.69K 4,170 at 13.12
2.8%
Planned (10b5-1)
6 Apr 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan
$56.01K 4,170 at 13.43
2.7%
Planned (10b5-1)
2 Mar 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan
$62.59K 4,170 at 15.01
2.7%
Planned (10b5-1)
2 Mar 2026
Watkins Tim CMO & Head of Development
Sold on a plan
$54.22K 3,611 at 15.02
100%
Sold half or more
25 Feb 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan
$61.23K 3,824 at 16.01
2.4%
Planned (10b5-1)
25 Feb 2026
Stengone Carmine N. CEO and President
Sold on a plan
$43.24K 2,700 at 16.02
15.3%
Planned (10b5-1)
24 Feb 2026
Stengone Carmine N. CEO and President
Sold on a plan
$70.49K 4,400 at 16.02
22.7%
Planned (10b5-1)
24 Feb 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan
$68.94K 4,300 at 16.03
2.7%
Planned (10b5-1)
19 Feb 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan
$1.60K 100 at 16.00
0.1%
Planned (10b5-1)
11 Feb 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan
$6.40K 400 at 16.00
0.3%
Planned (10b5-1)
11 Feb 2026
Stengone Carmine N. CEO and President
Sold on a plan
$6.40K 400 at 16.00
2.6%
Planned (10b5-1)
3 Feb 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan 2×
$62.31K 4,170 at 14.94
2.6%
Planned (10b5-1)
28 Jan 2026
Watkins Tim CMO & Head of Development
Sold on a plan 2×
$51.19K 3,611 at 14.18
100%
Sold half or more
5 Jan 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan 2×
$43.54K 4,170 at 10.44
2.5%
Planned (10b5-1)
29 Dec 2025
Watkins Tim CMO & Head of Development
Sold on a plan
$43.56K 3,611 at 12.06
100%
Sold half or more
23 Dec 2025
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan
$51.01K 4,170 at 12.23
2.5%
Planned (10b5-1)
Showing 1–26 of 26.